Bank of Nova Scotia’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $468K | Buy |
1,628
+105
| +7% | +$30.2K | ﹤0.01% | 839 |
|
|
2025
Q1 | $469K | Sell |
1,523
-194
| -11% | -$59.8K | ﹤0.01% | 805 |
|
|
2024
Q4 | $606K | Sell |
1,717
-1,420
| -45% | -$501K | ﹤0.01% | 821 |
|
|
2024
Q3 | $1.12M | Buy |
3,137
+779
| +33% | +$279K | ﹤0.01% | 739 |
|
|
2024
Q2 | $751K | Sell |
2,358
-69,280
| -97% | -$22.1M | ﹤0.01% | 795 |
|
|
2024
Q1 | $16.5M | Buy |
71,638
+46,759
| +188% | +$10.7M | 0.03% | 303 |
|
|
2023
Q4 | $5.47M | Buy |
24,879
+21,822
| +714% | +$4.8M | 0.01% | 502 |
|
|
2023
Q3 | $690K | Sell |
3,057
-1,052
| -26% | -$238K | ﹤0.01% | 761 |
|
|
2023
Q2 | $907K | Sell |
4,109
-225
| -5% | -$49.7K | ﹤0.01% | 690 |
|
|
2023
Q1 | $971K | Buy |
+4,334
| New | +$971K | ﹤0.01% | 707 |
|
|
2022
Q2 | – | Sell |
-115,371
| Closed | -$20.7M | – | 1239 |
|
|
2022
Q1 | $20.7M | Buy |
115,371
+110,452
| +2,245% | +$19.8M | 0.04% | 326 |
|
|
2021
Q4 | $1.06M | Sell |
4,919
-172,277
| -97% | -$37.2M | ﹤0.01% | 940 |
|
|
2021
Q3 | $32.7M | Buy |
177,196
+174,351
| +6,128% | +$32.2M | 0.06% | 256 |
|
|
2021
Q2 | $510K | Sell |
2,845
-100
| -3% | -$17.9K | ﹤0.01% | 937 |
|
|
2021
Q1 | $493K | Sell |
2,945
-1,054
| -26% | -$176K | ﹤0.01% | 915 |
|
|
2020
Q4 | $607K | Sell |
3,999
-1,269
| -24% | -$193K | ﹤0.01% | 818 |
|
|
2020
Q3 | $532K | Buy |
5,268
+1,177
| +29% | +$119K | ﹤0.01% | 827 |
|
|
2020
Q2 | $495K | Buy |
+4,091
| New | +$495K | ﹤0.01% | 749 |
|
|
2019
Q3 | – | Sell |
-31,577
| Closed | -$2.47M | – | 949 |
|
|
2019
Q2 | $2.47M | Buy |
31,577
+10,577
| +50% | +$826K | 0.01% | 562 |
|
|
2019
Q1 | $2.47M | Buy |
+21,000
| New | +$2.47M | 0.01% | 579 |
|